@_whatmakesaman_'s TRT marketing claims, fact-checked

What does this video actually claim?

Andrew Bernie Bernard (@_whatmakesaman_) argues that low testosterone concerns are largely manufactured by marketers exploiting "red-pill panic." He suggests men are being manipulated into worrying about T levels as part of a broader marketing strategy targeting male insecurities.

The video positions itself as debunking testosterone replacement therapy hype. Bernard frames TRT promotion as a grift that preys on men's anxieties about masculinity and performance.

Is testosterone deficiency actually overdiagnosed?

Bernard's core point has merit. TRT prescriptions increased 300% between 2001-2011, according to Baillargeon et al. (JAMA Internal Medicine, 2013), often without proper testing protocols. The same study found that only 19% of men received appropriate follow-up testosterone testing.

The Endocrine Society's 2018 guidelines require two separate morning testosterone measurements below 300 ng/dL plus symptoms for diagnosis. Yet many clinics skip this standard, instead using broader "optimization" language to treat men with normal levels.

Direct-to-consumer TRT marketing exploded alongside social media. Companies like Hims, Roman, and dozens of "hormone optimization" clinics now advertise heavily on platforms targeting men aged 25-45.

What did Bernard get wrong about legitimate treatment?

Bernard's dismissal goes too far. True hypogonadism affects 2-4% of adult men, per Araujo et al. (Journal of Clinical Endocrinology & Metabolism, 2007). These men have genuinely low testosterone (under 300 ng/dL) and real symptoms like fatigue, depression, and sexual dysfunction.

The TRAVERSE trial (Lincoff et al., NEJM, 2023) followed 5,246 men for an average of 22 months. It found TRT didn't increase cardiovascular risk in men with documented hypogonadism, addressing a key safety concern.

Legitimate medical societies like the American Urological Association do recognize hypogonadism as a real condition requiring treatment when properly diagnosed.

How big is the TRT marketing problem?

The numbers back Bernard's skepticism about marketing tactics. A 2017 study in JAMA found that 25% of men starting TRT never had their testosterone levels tested beforehand. Another 20% had normal levels but received treatment anyway.

"Low T" advertising spend reached $200 million annually by 2013, according to FDA data. The agency actually required AbbVie to run corrective ads after finding their AndroGel marketing overstated benefits and understated risks.

Social media influencers now promote TRT without medical credentials. Many don't disclose financial relationships with clinics or supplement companies, violating FTC guidelines.

What should men actually know about testosterone?

Get proper testing if you have genuine symptoms. That means two early morning blood draws showing levels below 300 ng/dL, not a single test or online questionnaire.

Normal testosterone ranges from 300-1000 ng/dL. Most healthy men don't need levels at the top of this range. The idea that 800+ ng/dL is automatically better lacks scientific support.

Lifestyle changes can boost testosterone naturally. Sleep, exercise, and weight management matter more than supplements. A 2011 study found that losing 17 pounds increased testosterone by 15%.